A Response-Adapted Clinical Trial of Weekly Carfilzomib With or Without Rituximab for Waldenström's Macroglobulinemia and Marginal Zone Lymphoma
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Carfilzomib (Primary) ; Rituximab (Primary)
- Indications Marginal-zone-B-cell-lymphoma; Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 26 Dec 2017 Status changed from not yet recruiting to recruiting.
- 13 Nov 2017 Planned initiation date changed from 11 Oct 2017 to 13 Dec 2017.